elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39200194-11D30917-E8B2-4490-9DB5-C298BD5C333C
Q39200194-11D30917-E8B2-4490-9DB5-C298BD5C333C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39200194-11D30917-E8B2-4490-9DB5-C298BD5C333C
Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.
P2860
Q39200194-11D30917-E8B2-4490-9DB5-C298BD5C333C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39200194-11D30917-E8B2-4490-9DB5-C298BD5C333C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
df9c636d6e9c3d14b063e510aae6ad9a5fab8bff
P2860
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.